4.2.2.3 / June 12, 2019
(3.9/5) (1448)
Loading...

Description

(Application contains data on CEPHALOSPORINS only by default.Complete Data is available through yearly subscriptions. Usershaving complementary Scratch cards can use app with complete datafor One Month) Instant and Predictive Search by: Brand Generic Name(e.g. Cefoperazone) Contents (e.g. Cefoperazone and Sulbactam)Therapeutic Category (e.g. Cephalosporins) Interaction Checker:Interaction Checker feature lets you quickly identify anyinteraction(s) among prescribed drugs. You can select GENERICS aswell as BRANDS in your country to check interaction. Risk FactorsInformation provided under Risk Factors include Contraindications,Precautions and Risks in Pregnancy and Lactation for the relevantproduct. Pregnancy: Risk cannot be ruled out. Lactation:Contraindicated. Contraindications: Severe respiratory depression,severe obstructive lung conditions. Precautions: COPD, raisedintracranial pressure, impaired consciousness, head injury,bradyarrhythmia, renal or hepatic impairment. Monitor for signs ofrespiratory depression. Brain tumour. Risk of tolerance anddependence. Elderly or debilitated patients. Dosage (AlongwithIndications) Fast, Quick & Easy Access to Accurate Dosage inSpecific Indications The usual dosage are: Adults: Usually 1 gmdaily by deep IM., slow IV inj over at least 2-4 min, or IVinfusion. Severe infections, 2-4 gm as a single dose every 24 hrs.Children: Usually 20-50 mg/kg once daily by IM inj., slow IV injover at least 2-4 min, or IV infusion. Severe infections, up tomaximum 80 mg/kg daily. Doses over 50 mg/kg to be given by slow IVinfusion over at least 30 minutes. Neonates: IM/IV: Postnatal age ≤7 days or > 7 days (body wt ≤ 2 Kg): 50 mg/kg/day given every 24hrs. Postnatal age > 7 days, body wt > 2 Kg: 50-75 mg/kg/daygiven every 24 hrs. Administration How to prepare and administere.g. an Injectable The drug may be administered by IV intermittentinfusion over 10-30 min; final concentration for IV administrationshould not exceed 40 mg/mL. The drug has also been administered bydirect IV push over 2-4 min. Inject deep IM into large muscle mass.IM Injection: 250 mg/500 mg/1000 mg VIAL: To make concentration of250 mg/mL add Water for Injection 0.9 mL in 250 mg vial; 1.8 mL in500 mg vial; 3.6 mL in 1000 mg vial. IV: 250 mg/500 mg/1000 mgVIAL: To make concentration of 100 mg/mL add Water for Injection2.4 mL in 250 mg vial; 4.8 mL in 500 mg vial; 9.6 mL in 1000 mgvial. Compatibility: Stable in D5W, D10W, NS, Sodium bicarbonate5%, bacteriostatic water, SWFI. Stability: For IV infusion in NS orD5W, solution is stable for 3 days at room temperature or 10 dayswhen refrigerated. Interactions Amikacin, Aminoglycosides,Anticoagulants, Gentamicin, Kanamycin, Neomycin, Netilmicin,Streptomycin, Tobramycin, Warfarin. Adverse Effects GI upset, skinreactions, blood dyscrasias. Rarely pseudomembranous colitis,raised liver enzymes, glycosuria, oliguria, haematuria,bronchospasm, phlebitis at inj site, urinary and biliaryprecipitates, pancreatitis. Alternate Products Quickly findAlternate Products - Just Click the Appropriate Button

App Information PharmaGuide

PharmaGuide Version History

Select PharmaGuide Version :
  • 4.2.2.1 (45)
  • 4.1.1.0 (42)
  • 3.2 (24)
  • PharmaGuide 4.2.2.1 APK File

    Publish Date: 2019 /5/17
    Requires Android: Android 4.0.3+ (Ice Cream Sandwich, API: 15)
    File Size: 19.5 MB
    Tested on: Android 8.1 (Oreo, API: 27)
    File Sha1: c431ad1741e54cde835ebe0d546e2e927aa7213a
    APK Signature:
  • PharmaGuide 4.1.1.0 APK File

    Publish Date: 2017 /2/16
    Requires Android: Android 4.0.3+ (Ice Cream Sandwich, API: 15)
    File Size: 19.1 MB
    Tested on: Android 4.0.3 (Ice Cream Sandwich, API: 15)
    File Sha1: 9899e304f1906788770bfbe088f086251605e3ed
    APK Signature: 966de5bdf97f6a177f41fcfe14a8d50cc919b40a
  • PharmaGuide 3.2 APK File

    Publish Date: 2016 /2/19
    Requires Android: Android 2.2+ (Froyo, API: 8)
    File Size: 1.3 MB
    Tested on: Android 4.1 (Jelly Bean, API: 16)
    File Sha1: d7847bff9379a1d04e52a9c4dcb2f54b7b4754cd
    APK Signature: 966de5bdf97f6a177f41fcfe14a8d50cc919b40a

PharmaGuide Publishing Company Show More...

PharmaGuide 4.2.2.3 APK
(Application contains data on CEPHALOSPORINS only by default.Complete Data is available through yearly subscriptions. Usershaving complementary Scratch cards can use app with complete datafor One Month) Instant and Predictive Search by: Brand Generic Name(e.g. Cefoperazone) Contents (e.g. Cefoperazone and Sulbactam)Therapeutic Category (e.g. Cephalosporins) Interaction Checker:Interaction Checker feature lets you quickly identify anyinteraction(s) among prescribed drugs. You can select GENERICS aswell as BRANDS in your country to check interaction. Risk FactorsInformation provided under Risk Factors include Contraindications,Precautions and Risks in Pregnancy and Lactation for the relevantproduct. Pregnancy: Risk cannot be ruled out. Lactation:Contraindicated. Contraindications: Severe respiratory depression,severe obstructive lung conditions. Precautions: COPD, raisedintracranial pressure, impaired consciousness, head injury,bradyarrhythmia, renal or hepatic impairment. Monitor for signs ofrespiratory depression. Brain tumour. Risk of tolerance anddependence. Elderly or debilitated patients. Dosage (AlongwithIndications) Fast, Quick & Easy Access to Accurate Dosage inSpecific Indications The usual dosage are: Adults: Usually 1 gmdaily by deep IM., slow IV inj over at least 2-4 min, or IVinfusion. Severe infections, 2-4 gm as a single dose every 24 hrs.Children: Usually 20-50 mg/kg once daily by IM inj., slow IV injover at least 2-4 min, or IV infusion. Severe infections, up tomaximum 80 mg/kg daily. Doses over 50 mg/kg to be given by slow IVinfusion over at least 30 minutes. Neonates: IM/IV: Postnatal age ≤7 days or > 7 days (body wt ≤ 2 Kg): 50 mg/kg/day given every 24hrs. Postnatal age > 7 days, body wt > 2 Kg: 50-75 mg/kg/daygiven every 24 hrs. Administration How to prepare and administere.g. an Injectable The drug may be administered by IV intermittentinfusion over 10-30 min; final concentration for IV administrationshould not exceed 40 mg/mL. The drug has also been administered bydirect IV push over 2-4 min. Inject deep IM into large muscle mass.IM Injection: 250 mg/500 mg/1000 mg VIAL: To make concentration of250 mg/mL add Water for Injection 0.9 mL in 250 mg vial; 1.8 mL in500 mg vial; 3.6 mL in 1000 mg vial. IV: 250 mg/500 mg/1000 mgVIAL: To make concentration of 100 mg/mL add Water for Injection2.4 mL in 250 mg vial; 4.8 mL in 500 mg vial; 9.6 mL in 1000 mgvial. Compatibility: Stable in D5W, D10W, NS, Sodium bicarbonate5%, bacteriostatic water, SWFI. Stability: For IV infusion in NS orD5W, solution is stable for 3 days at room temperature or 10 dayswhen refrigerated. Interactions Amikacin, Aminoglycosides,Anticoagulants, Gentamicin, Kanamycin, Neomycin, Netilmicin,Streptomycin, Tobramycin, Warfarin. Adverse Effects GI upset, skinreactions, blood dyscrasias. Rarely pseudomembranous colitis,raised liver enzymes, glycosuria, oliguria, haematuria,bronchospasm, phlebitis at inj site, urinary and biliaryprecipitates, pancreatitis. Alternate Products Quickly findAlternate Products - Just Click the Appropriate Button
PharmaGuide GCC 1.5.3 APK
PharmaGuide GCC Edition contains data on oneTherapeutic Category by default as a sample. Complete Data isavailable through yearly subscriptions. Users having complementaryscratch cards can use the application with complete data for onemonth.PharmaGuide GCC Edition includes features of mass customizationwhich means that the user can view the information of all 6 GCCcountries (i.e. Bahrain, Kuwait, Oman, Qatar, Saudi Arabia andUnited Arab Emirates).PharmaGuide GCC Edition provides instant and predictive searchby:Brand Name, Generic Name, Contents, Therapeutic Category andCompanyThe following information are provided:Risk Factors, Dosage (along with indications), Administration,Interactions, Adverse Effects and Alternate Products
com.pg.sals 1.3.6 APK
Sals provides sales analysis of: SALES GROWTH SHARE RANKING DATATREND Analyze by Brand Company Dosage Form/Strength ContentTherapeutic Category
Loading...